Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five ...

A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from ...

The disease is characterized by the formation ... plays a pivotal role in the progression of α-synuclein pathology in Parkinson’s disease, highlighting its potential as a therapeutic target ...

A recent study reveals an immune mechanism that could explain why Parkinson's disease affects more men than women. This ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in counteracting key pathological mechanisms associated with Parkinson's disease ...

2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a significant ...

A GROUNDBREAKING study has identified rare genetic variants in the ITSN1 gene that increase Parkinson’s disease risk by up to tenfold and reveal unexpected links to autism spectrum disorder (ASD), ...

Parkinson's Disease has an early onset form, which affects patients before they reach age 50, and is due to genetic mutations. | Genetics And Genomics ...

WEHI researchers have made a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery that paves the way for development of new drugs to treat the condition.

Scientists have identified a rare genetic mutation in ITSN1 that increases the risk of Parkinson’s disease by up to tenfold, ...

A new study published in Cell Reports reveals a breakthrough discovery linking genetic variants in the gene ITSN1 to a significantly elevated risk of Parkinson's disease, a neurodegenerative condition ...